April 15, 2026
Authored and Edited by Christine M. Akagi; Ryan V. McDonnell; Erik R. Puknys
In The Trustees of Columbia University in the City of New York v. Gen Digital Inc., No. 2024-1243 (Fed. Cir. Mar. 11, 2026), the Federal Circuit vacated an infringement judgment, reversed a district court’s determination that the claims of the asserted patents were not directed to an abstract idea, and remanded for further proceedings on patent eligibility.
Columbia sued Gen Digital, the maker of Norton software, for infringement of patents relating to computer security. Gen Digital moved for judgment on the pleadings, arguing that the claims were patent-ineligible under 35 U.S.C. § 101. The district court denied the motion because it determined that the claims were directed not to an abstract idea but to an improvement in computer-virus scanning using multiple computers in a divide-and-conquer approach that improved efficiency. The district court later struck the section 101 defense, and the case proceeded to a jury trial that resulted in a willful infringement verdict and damages award of over $185 million. Gen Digital appealed.
The Federal Circuit reversed the district court’s patent eligibility determination. The Court determined that the claims recited conventional components and that the divide-and-conquer approach and the efficiency gains allegedly associated with it are abstract ideas. Moreover, the Court determined that the technical improvements Columbia asserted were not reflected in the claim language. As a result, the Federal Circuit held that the claims were directed to an abstract idea and remanded for consideration under the second step of the patent-eligibility framework.
patentable subject matter, 35 U.S.C. § 101, United States Court of Appeals for the Federal Circuit (CAFC)
Copyright © 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
At the PTAB Blog
Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a
§ 325(d) EPR Denial
May 28, 2026
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026
May 26, 2026
At the PTAB Blog
May 20, 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.